Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Autoimmune Pancreatitis: From Pathogenesis to Treatment. | Int J Mol Sci | 2022 | 36293522 | PubTator, text mining | PubMed |
| Radiotherapy-Related Gene Signature in Prostate Cancer. | Cancers (Basel) | 2022 | 36291815 | PubTator, text mining | PubMed |
| Targeting the high affinity receptor, FcγRI, in autoimmune disease, neuropathy, and cancer. | Immunother Adv | 2022 | 36284837 | PubTator, text mining | PubMed |
| IMGT ® Nomenclature of Engineered IGHG Variants Involved in Antibody Effector Properties and Formats. | Antibodies (Basel) | 2022 | 36278618 | PubTator, text mining | PubMed |
| Comparative analysis of the repertoire of insulin-reactive B cells in type 1 diabetes-prone and resistant mice. | Front Immunol | 2022 | 36275764 | PubTator, text mining | PubMed |
| On the role of allergen-specific IgG subclasses for blocking human basophil activation. | Front Immunol | 2022 | 36275723 | PubTator, text mining | PubMed |
| Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease. | Front Microbiol | 2022 | 36274722 | PubTator, text mining | PubMed |
| Tumor buster - where will the CAR-T cell therapy 'missile' go? | Mol Cancer | 2022 | 36261831 | PubTator, text mining | PubMed |
| A Rare Case of HIV-Induced Neutropenia Resulting in Haemophilus influenzae Septic Oligoarthritis: A Case-Based Literature Review. | Cureus | 2022 | 36258953 | PubTator, text mining | PubMed |
| BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age. | Cell Rep | 2022 | 36252569 | PubTator, text mining | PubMed |
| New Mechanistic Advances in FcεRI-Mast Cell-Mediated Allergic Signaling. | Clin Rev Allergy Immunol | 2022 | 36251242 | PubTator, text mining | PubMed |
| Modulation of urelumab glycosylation separates immune stimulatory activity from organ toxicity. | Front Immunol | 2022 | 36248847 | PubTator, text mining | PubMed |
| Novel peanut-specific human IgE monoclonal antibodies enable screens for inhibitors of the effector phase in food allergy. | Front Immunol | 2022 | 36248809 | PubTator, text mining | PubMed |
| Systems biology and artificial intelligence analysis highlights the pleiotropic effect of IVIg therapy in autoimmune diseases with a predominant role on B cells and complement system. | Front Immunol | 2022 | 36248801 | PubTator, text mining | PubMed |
| Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia. | BMC Cancer | 2022 | 36243694 | PubTator, text mining | PubMed |
| Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment. | Life Sci Alliance | 2022 | 36241426 | PubTator, text mining | PubMed |
| Selective immunocapture reveals neoplastic human mast cells secrete distinct microvesicle- and exosome-like populations of KIT-containing extracellular vesicles. | J Extracell Vesicles | 2022 | 36239715 | PubTator, text mining | PubMed |
| IgG Glycosylation Profiling of Peripheral Artery Diseases with Lectin Microarray. | J Clin Med | 2022 | 36233595 | PubTator, text mining | PubMed |
| Recombinant Humanized IgG1 Antibody Protects against oxLDL-Induced Oxidative Stress and Apoptosis in Human Monocyte/Macrophage THP-1 Cells by Upregulation of MSRA via Sirt1-FOXO1 Axis. | Int J Mol Sci | 2022 | 36233020 | PubTator, text mining | PubMed |
| Structural Insights into the Binding Propensity of Human SHIP2 SH2 to Oncogenic CagA Isoforms from Helicobacter pylori. | Int J Mol Sci | 2022 | 36232599 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=37